What is Harvard Bioscience Inc (HBIO) stock price today?

Harvard Bioscience Inc (HBIO) currently trades at $6.38 per share. The stock has a market capitalization of $30.80M and a P/E ratio of —x.

Is HBIO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Harvard Bioscience Inc has a Smart Value Score of 40/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Harvard Bioscience Inc's revenue and earnings?

Harvard Bioscience Inc has trailing twelve-month (TTM) revenue of $86.55M with profit margins of -65.50%. Earnings per share (EPS) is $-12.80.

HBIO

Harvard Bioscience Inc

NASDAQ: HBIO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$6.38

+4.08% today

Updated 2026-04-30

Market cap

$30.80M

P/E ratio

—

P/S ratio

0.36x

EPS (TTM)

$-12.80

Dividend yield

—

52W range

$3 – $9

Volume

0.2M

Market cap

$30.80M

P/E ratio

—

P/S ratio

0.36x

EPS (TTM)

$-12.80

Dividend yield

—

52W range

$3 – $9

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

2.0

Growth

5.0

Quality

C+

3.5

Profitability

5.3

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$6.00

-5.96%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -65.50%

- Negative free cash flow $-545000.00

- Revenue declining -3.30% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$113.33M	$112.25M	$94.14M	$86.55M	$86.55M
Net income	$-9.52M	$-3.42M	$-12.40M	$-56.70M	$-2.85M
EPS	—	—	—	—	$-12.80
Free cash flow	$-438000.00	$11.72M	$-1.82M	$5.62M	$-545000.00
Profit margin	-8.40%	-3.04%	-13.18%	-65.51%	-65.50%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
HBIO	$30.80M	40	2.0	3.5	5.3	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Harvard Bioscience Inc trades at $6.38. Our Smart Value Score of 40/100 indicates the stock is fair. TTM revenue stands at $86.55M. with profit margins at -65.50%.

Frequently asked questions

What is Harvard Bioscience Inc's stock price?

Harvard Bioscience Inc (HBIO) trades at $6.38.

Is Harvard Bioscience Inc overvalued?

Smart Value Score 40/100 (Grade D, Sell).

What is the price target of Harvard Bioscience Inc (HBIO)?

The analyst target price is $6.00, representing -6.0% downside from the current price of $6.38.

What is Harvard Bioscience Inc's revenue?

TTM revenue is $86.55M.

Company info

SectorHEALTHCARE

IndustryMEDICAL INSTRUMENTS & SUPPLIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.36x

ROE-147.10%

Beta1.50

50D MA$5.52

200D MA$5.47

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

HBIO vs LLY →HBIO vs JNJ →HBIO vs ABBV →Stock screener →